Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology: A Systematic Review and Quantitative Analysis.

Overview of attention for article published in JAMA Internal Medicine, December 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 6 public wall posts from 5 users.

Revue systématique ne trouvant pas d’association entre l’augmentation de la durée de survie sans progression reliée à la…

Was bringt eine Chemotherapie, die nur eine Lebensverlängerung, aber keine Heilung versprechen kann? Auch eine Verbesserung der…

がん化学療法や生物学的がん治療薬に関する無作為比較試験において、progression-free survival (PFS) と健康関連 QOL には相関を認めない (文献2018-252)。 https://jamanetwork.com/journa…

This systematic review and analysis finds that for oncology patients, improvement in #PFS does not correlate with improvement…

Systematic review and analysis find that for #oncology patients, improvement in #PFS does not correlate with improvement in…

"Key…